Sundaram Preethi 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 31, 2024
Insider Transaction Report
Form 4
Sundaram Preethi
Chief Strategy Officer
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2024-12-27+6,667→ 36,648 total - Exercise/Conversion
Restricted Stock Units
2024-12-27−6,667→ 695,099 total→ Common Stock (6,667 underlying) - Tax Payment
Common Stock, par value $0.001 per share
2024-12-27−2,345→ 34,303 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
- [F3]Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 27, 2024.